Guaifenesin Tablet, Extended Release
Product Images NDC 58602-810

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 58602-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (600 mg (20 Tablet Label))

Package Label-principal Display Panel (600 mg (20 Tablet Label))
Guaifenesin Tablets 600 mg extended-release oral tablets by Aurohealth LLC. The label indicates it is an expectorant designed to relieve chest congestion and thin and loosen mucus, with a 12-hour effect. The package contains 20 tablets. The label includes detailed drug facts, usage instructions, and inactive ingredients.*
FDA Label Image

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))
Label for Guaifenesin Extended-Release Tablets 600 mg by Aurohealth LLC. The label is primarily teal and purple and displays the product name, strength, dosage form (extended-release tablets), and intended use as an expectorant to relieve chest congestion, thin and loosen mucus. The label also includes Drug Facts, directions, warnings, inactive ingredients, distributor information, and a barcode.*
FDA Label Image

Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))

Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))
Packaging label for Guaifenesin Extended-Release Tablets 600 mg, an expectorant by Aurohealth LLC. The label highlights relief of chest congestion, thinning and loosening of mucus, with 20 tablets per package. It indicates 12-hour extended release and includes standard drug facts, warnings, directions, and inactive ingredients. The label shows NDC 58602-810-96 and states the product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.